{"story":{"id":923612,"title":"Nearly 1 in 3 Stop SGLT2 Inhibitors Within a Year in Real-World Diabetes Study, and Most Don’t Restart Treatment - Medscape","permalink":"https://checknews.org/historia.php?id=923612","status":"quiet","category":"culture","country":"ET","country_name":"Ethiopia","language":"en","first_seen_at":"2026-10-08T03:04:30-06:00","last_activity_at":"2026-10-08T03:04:30-06:00","source_count":1,"article_count":1,"image":null,"articles":[{"title":"Nearly 1 in 3 Stop SGLT2 Inhibitors Within a Year in Real-World Diabetes Study, and Most Don’t Restart Treatment - Medscape","publisher":"Medscape","url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPRWdROE1uQy1XOW1LNEZfcXZrMTRrd1Q1Vk1qNG44MF9SVWlWVjZJLXdyVnJMbjlxMzRWVWNjazc5ajBaSUdxaFZNWENqY1d2bVVKb05QbVdZeklxaG10ZkpnekVWamZJbmlIMjVYa0EzcHhHLXZqdHp4eXJobTRfR1JvdjViRnVxY0FjZDgzakZZNXZaSzduakV5c01QSi1pd0tEazBEQ3k?oc=5","country":"ET","country_name":"Ethiopia","language":"en","published_at":"2026-10-08T03:04:30-06:00"}],"source_url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPRWdROE1uQy1XOW1LNEZfcXZrMTRrd1Q1Vk1qNG44MF9SVWlWVjZJLXdyVnJMbjlxMzRWVWNjazc5ajBaSUdxaFZNWENqY1d2bVVKb05QbVdZeklxaG10ZkpnekVWamZJbmlIMjVYa0EzcHhHLXZqdHp4eXJobTRfR1JvdjViRnVxY0FjZDgzakZZNXZaSzduakV5c01QSi1pd0tEazBEQ3k?oc=5","publishers":[{"name":"Medscape","country":"ET","country_name":"Ethiopia"}],"countries":["ET"]},"generated_at":"2026-11-17T02:34:27-06:00"}